Patient Care America
Karin Hehenberger is a highly experienced medical professional currently serving as President of Lyfebulb and Chief Medical Officer at Patient Care America since March 2024. With a robust background in medical consulting and advisory roles, Karin functions as a Medical Advisor for 3B Future Health Fund I & II and as a Medical and Scientific Consultant for Helsinn Group since January 2011. Additionally, Karin is an active board member for various organizations, including AnaCardio, Diamyd Medical, AADI biosciences, the American Diabetes Association (NY/NJ), and the Rolf Luft Foundation for Diabetes Research. Karin's previous role as Chief Executive Officer at Lyfebulb focused on empowering patients with chronic diseases. Academic credentials include a post-doctoral degree from Harvard Medical School and an MD/PhD from Karolinska Institutet.
This person is not in any offices
Patient Care America
Patient Care America is a healthcare service organization comprised of dedicated professionals committed to the highest quality patient care to achieve optimal therapeutic outcomes. The company focus is in specialty pharmacy which addresses the needs of the renal nutrition market through custom Intradialytic Parenteral Nutrition formulations under the brand names NutriRite IDPN therapy and NutriRite Home IDPN and IPN therapy.